SINGAPORE--(BUSINESS WIRE)--Prestige BioPharma Ltd. (hereinafter “Prestige BioPharma”) today announced that the European Medicines Agency (EMA) Orphan Drug Commission (COMP) has granted a positive opinion...
LACHEN, Switzerland--(BUSINESS WIRE)--Octapharma is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved an updated Prescribing Information (PI) for NUWIQ®,...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc., (Nasdaq: VCYT) today announced that new data presented at the CHEST Annual Meeting 2020 show that a genomic...
DUBLIN--(BUSINESS WIRE)--Inflection Biosciences Ltd, a company developing innovative therapeutics for the treatment of cancer, today announced the appointment of industry veteran Gregory I. Berk,...
MANHASSET, N.Y.--(BUSINESS WIRE)--Since coronavirus disease 2019 (COVID-19) emerged, researchers and doctors have suggested that the infection provokes a destructive immune response known as a...
ZURICH, Switzerland--(BUSINESS WIRE)--Versantis AG, a clinical-stage company developing novel therapies for orphan liver diseases, today announced that the U.S. Food and Drug Administration (FDA)...
LUXEMBOURG--(BUSINESS WIRE)--Eurofins U.S. Clinical Diagnostics, announced that Clinical Enterprise Inc. has received an Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration...
BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is focused on advancing health and guiding patient care, today announced a...
